News
Latest Posts
What is Psilocybin?
You might have heard of the hallucinogenic drug called ‘Magic Mushrooms’ which is referred to as psilocybin, but did you
Living with Eczema in the Summer
For people living with eczema, summer can be a tricky time. The heat and humidity can trigger flare ups while
What is Drug Repurposing?
Developing new medicine can be a very long process, spanning over years. In fact, on average, it takes at least
Treating Mild Cognitive Impairment
Mild Cognitive Impairment (MCI) is a condition in which someone has some difficulty with cognition – so, their mental abilities
Living with Lewy Body Dementia
Dementia with Lewy bodies (DLB), also known as Lewy Body dementia, is one of the most common types of dementia.
MAC Clinical Research has been appointed to accelerate timeline of Phase I/IIa clinical trial for Major Depressive Disorder
Small Pharma Inc., a neuro-pharmaceutical company focused on psychedelic-assisted therapy, have announced the expansion of its phase I/IIa clinical trial
Aducanumab for the treatment of Alzheimer’s
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the new drug Aducanumab for the treatment of Alzheimer’s,
What are Opioids?
Opioids are medications prescribed by doctors to treat persistent or severe pain. They can either be sourced synthetically or derived
Featured Posts
Categories
Follow Us
Follow MAC Clinical Research on social media to keep up to date with our latest news and clinical trials.
